Brian Kim, MD: Pushing Dermatology Forward and Alys Pharmaceuticals
Kim discusses the state of dermatology innovation and applied care, as well as his involvement in a new company in the space.
Source: hcplive.com
Stay updated with breaking news from Alys Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kim discusses the state of dermatology innovation and applied care, as well as his involvement in a new company in the space.
In preclinical testing, combining BioAge Labs’ experimental drug with Eli Lilly weight drug Zepbound led to greater weight loss compared with Zepbound alone. Now the company plans to run a Phase 2 study to see if it can replicate those results in humans.
Alys Pharmaceuticals, an immuno-dermatology focused company, has launched with $100 million financing by Medicxi and an R&D pipeline enabled by multiple platform technologies.